News | July 26, 2023
Syngene Q1 FY 2024 revenue up 26% to Rs. 832 crores, PAT up 26% to Rs.93 Cr
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Health-tech startups have the potential to revolutionize the healthcare sector by supporting innovations
Apollo Transplant program is the first program in India to cross the landmark of 18500 kidney transplants, 4300 liver transplants and 500 pediatric liver transplants
Traditional medicine effectively highlighted in all health and engagement working groups meeting and Ministry of Ayush acknowledges these efforts
Good momentum in commercial CDMO business
First of its kind screening for Glaucoma at grass root level over 10k screened already
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
This product will be launched through Granules Consumer Health (GCH) division
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
_256_384.jpg)
The collaboration aims to raise awareness about eye cancer, provide medical and surgical treatment support to children and supply nutritional supplements to aid in their faster recovery.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
